🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases

RecruitingNAAges 60 Years - anyAllNational University of Malaysia
NCT07843238 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to evaluate a newly developed virtual care program for older adults with chronic diseases (hypertension, diabetes and lipid disorders) whether it is feasible and economical to implement in the Malaysian primary healthcare settings. Investigators hypothesize that the use of this virtual care program (TeleCOOP-NCD©) will be more cost-effective (lower total costs per benefits gained) compared to the usual onsite care at the clinic for older adults who have stable chronic diseases. The investigators also hypothesize that there is no significant difference in control of clinical parameters compared to usual care. Researchers will compare the primary outcomes such as patient satisfaction, health-related quality of life, provider cost and patient cost between the intervention and control group. Researchers will also check participant recruitment rate, participant re

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with the age of 60 years and above; * Patients who are literate in either Malay or English language; * Patients who are not frail or mildly frail (with the scores of 0-8 in the Pictorial Fit-Frail Scale assessment); * Patients who are receiving treatment for hypertension, diabetes and/or dyslipidemia (any of the three NCDs); and * Patients who have internet access and know how to operate a smartphone/device or are able to receive assistance for its use from their family members or caregivers. Exclusion Criteria: * Patients who are completely transferred out from the Klinik Primer or Hospital Canselor Tuanku Muhriz (HCTM); * Patients who are newly referred to the clinic and attending their first visit; * Patients who visit the clinic for teaching sessions or non-doctor consultations (allied health, procedures, or prescription refill).
💊

What it tests

  • Teleconsultation care pathway for older adults with NCDs (TeleCOOP-NCD©)
📍

Where

1 site
Klinik Primer - Hospital Canselor Tuanku Muhriz (KP-HCTM)
Kuala Lumpur, Malaysia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy